Kite Pharma, Inc. (NASDAQ:KITE) belongs to Healthcare sector. Its weekly performance is 8.90%. On last trading day company shares ended up $64.21. Kite Pharma, Inc. (NASDAQ:KITE) distance from 50-day simple moving average (SMA50) is 13.10%. On 1st July, Kite Pharma, Inc., (NASDAQ:KITE) and The Leukemia & Lymphoma Society (LLS) announced today that they have entered into a partnership to enhance the development of Kite’s lead product candidate, KTE-C19, for the treatment of patients with refractory aggressive non-Hodgkin lymphoma (NHL). KTE-C19 is an investigational therapy in which a patient’s T cells are genetically modified to express a Chimeric Antigen Receptor (CAR) designed to target CD19, a protein expressed on the cell surface of B cell lymphomas and leukemias.
eLong Inc. (NASDAQ:LONG) shares moved down -7.23% in last trading session and ended the day at $14.11. LONG Gross Margin is 58.70% and its return on assets is -15.50%. eLong Inc. (NASDAQ:LONG) quarterly performance is -18.63%. eLong (NASDAQ:LONG) was downgraded by Zacks from a “hold” rating to a “sell” rating in a report released on Saturday.
On 07 July, ATA, Inc. (NASDAQ:ATAI) shares moved down -3.54% and was closed at $4.90. ATAI EPS growth in last 5 year was 21.40%. ATA, Inc. (NASDAQ:ATAI) year to date (YTD) performance is 12.39%. On 24 June, ATA Inc. (NASDAQ: ATAI), announced that it has filed its annual report on Form 20-F for the fiscal year ended March 31, 2015, with the U.S. Securities and Exchange Commission.
Audience, Inc. (NASDAQ:ADNC) ended the last trading day at $4.89. Company weekly volatility is calculated as 2.84%. Audience, Inc. (NASDAQ:ADNC) showed a weekly performance of -3.36%. On June 30, 2015 Based on preliminary information from Computershare, the exchange agent for the Offer, 21,349,817 Audience Inc. (NASDAQ:ADNC) shares, representing over 89.1 percent of the outstanding Audience shares as of the close of business on June 30, 2015, were validly tendered and not validly withdrawn prior to the expiration of the Offer. All of such Audience shares have been accepted for payment in accordance with the terms of the Offer, including 1,534,095 of such Audience shares that were tendered pursuant to the Offer’s guaranteed delivery procedure.
South Jersey Industries, Inc. (NYSE:SJI) shares increased 1.68% in last trading session and ended the day at $25.40. SJI Gross Margin is 40.10% and its return on assets is 3.20%. South Jersey Industries, Inc. (NYSE:SJI) quarterly performance is -5.28%. South Jersey Industries (NYSE: SJI) declared a quarterly dividend of $0.25125 per share, or $1.005 annualized.
The dividend will be payable on October 2, 2015, to stockholders of record on September 10, 2015, with an ex-dividend date of September 8, 2015.